99mTc-3P4-RGD2

N/A

Report date: 2025/09/08 11:00:35
NME

Base Information

Drug Name99mTc-3P4-RGD2
Drug Alias NamealphaV-beta3 integrin receptor-targeted imaging agent
ClassificationDiagnostic agent (In vivo)Small moleculesRadiation-emitting products > Radioactive diagnostic agent +[5] 
Mechanisms of ActionIntegrin alpha-V/beta-3 modulators
TargetsIntegrin alpha-V/beta-3
Therapy Area/IndicationsArthritis, RheumatoidLung NeoplasmsEsophageal Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesPeking UniversityPurdue UniversityStanford University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChinese Academy Of Medical Science & Peking Union Medical CollegeFirst Affiliated Hospital Of Fujian Medical UniversityStanford University +[5] 
Active IndicationsN/A
Inactive IndicationsArthritis, RheumatoidLung NeoplasmsEsophageal Neoplasms +[4] 

Other Information

ATC CodeN/A
Related LinksN/A